The Medicines and Healthcare products Regulatory Agency (MHRA) advises discontinuing these GLP-1 receptor agonists if pregnancy is planned or confirmed
While off-licence prescribing can be common in some areas of medicine [60], it can also pose safety risks [61]particularly when medications are accessed without appropriate clinical supervision
Charakteristisch sind ein verminderter Appetit, eine reduzierte Nahrungsaufnahme, Energie- und Nhrstoffdefizite, eine gesteigerte Katabolie sowie ein ungewollter Gewichtsverlust (15)
MOTS-c is a mitochondrial peptide associated with metabolism, stress response, and aspects of ageing and disease
Other common symptoms include fatigue, post-exertional malaise, sleep problems, brain fog, poor brain function, muscle spasms, rashes, problems standing, irritable bowel symptoms, muscle weakness, myoclonic twitches, pelvic pain, poor coordination, and hypoglycemia